Gain-of-Function Research: Ethical Analysis

被引:0
|
作者
Michael J. Selgelid
机构
[1] Monash University,Centre for Human Bioethics
来源
关键词
Gain-of-function research; Dual-use research; Biosafety; Biosecurity; Risk-benefit assessment; Decision theory;
D O I
暂无
中图分类号
学科分类号
摘要
Gain-of-function (GOF) research involves experimentation that aims or is expected to (and/or, perhaps, actually does) increase the transmissibility and/or virulence of pathogens. Such research, when conducted by responsible scientists, usually aims to improve understanding of disease causing agents, their interaction with human hosts, and/or their potential to cause pandemics. The ultimate objective of such research is to better inform public health and preparedness efforts and/or development of medical countermeasures. Despite these important potential benefits, GOF research (GOFR) can pose risks regarding biosecurity and biosafety. In 2014 the administration of US President Barack Obama called for a “pause” on funding (and relevant research with existing US Government funding) of GOF experiments involving influenza, SARS, and MERS viruses in particular. With announcement of this pause, the US Government launched a “deliberative process” regarding risks and benefits of GOFR to inform future funding decisions—and the US National Science Advisory Board for Biosecurity (NSABB) was tasked with making recommendations to the US Government on this matter. As part of this deliberative process the National Institutes of Health commissioned this Ethical Analysis White Paper, requesting that it provide (1) review and summary of ethical literature on GOFR, (2) identification and analysis of existing ethical and decision-making frameworks relevant to (i) the evaluation of risks and benefits of GOFR, (ii) decision-making about the conduct of GOF studies, and (iii) the development of US policy regarding GOFR (especially with respect to funding of GOFR), and (3) development of an ethical and decision-making framework that may be considered by NSABB when analyzing information provided by GOFR risk-benefit assessment, and when crafting its final recommendations (especially regarding policy decisions about funding of GOFR in particular). The ethical and decision-making framework ultimately developed is based on the idea that there are numerous ethically relevant dimensions upon which any given case of GOFR can fare better or worse (as opposed to there being necessary conditions that are either satisfied or not satisfied, where all must be satisfied in order for a given case of GOFR to be considered ethically acceptable): research imperative, proportionality, minimization of risks, manageability of risks, justice, good governance (i.e., democracy), evidence, and international outlook and engagement. Rather than drawing a sharp bright line between GOFR studies that are ethically acceptable and those that are ethically unacceptable, this framework is designed to indicate where any given study would fall on an ethical spectrum—where imaginable cases of GOFR might range from those that are most ethically acceptable (perhaps even ethically praiseworthy or ethically obligatory), at one end of the spectrum, to those that are most ethically problematic or unacceptable (and thus should not be funded, or conducted), at the other. The aim should be that any GOFR pursued (and/or funded) should be as far as possible towards the former end of the spectrum.
引用
收藏
页码:923 / 964
页数:41
相关论文
共 50 条
  • [21] CRISPR gain-of-function screens
    Nicole Rusk
    Nature Methods, 2015, 12 : 102 - 103
  • [22] CRISPR GAIN-OF-FUNCTION SCREENS
    Rusk, Nicole
    NATURE METHODS, 2015, 12 (02) : 102 - 103
  • [23] Does influenza pandemic preparedness and mitigation require gain-of-function research?
    Adam, Dillon C.
    Magee, Daniel
    Bui, Chau M.
    Scotch, Matthew
    MacIntyre, C. Raina
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2017, 11 (04) : 306 - 310
  • [24] European Academies Advise on Gain-of-Function Studies in Influenza Virus Research
    Fears, Robin
    ter Meulen, Volker
    JOURNAL OF VIROLOGY, 2016, 90 (05) : 2162 - 2164
  • [25] Evaluation of mTOR function by a gain-of-function approach
    Ohne, Yoichiro
    Takahara, Terunao
    Maeda, Tatsuya
    CELL CYCLE, 2009, 8 (04) : 573 - 579
  • [26] Analysis of sperm galactosyltransferase through gain-of-function and loss-of-function mutations
    Shur, B
    Lu, QX
    Shi, XD
    Paruchuru, K
    Miller, D
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 7A - 7A
  • [27] Ban on gain-of-function studies ends
    Burki, Talha
    LANCET INFECTIOUS DISEASES, 2018, 18 (02): : 148 - 149
  • [28] House OKs gain-of-function ban
    Brainard, Jeffrey
    SCIENCE, 2023, 382 (6673) : 862 - 862
  • [29] Systematic gain-of-function genetics in Drosophila
    Rorth, P
    Szabo, K
    Bailey, A
    Laverty, T
    Rehm, J
    Rubin, GM
    Weigmann, K
    Milán, M
    Benes, V
    Ansorge, W
    Cohen, SM
    DEVELOPMENT, 1998, 125 (06): : 1049 - 1057
  • [30] GABAergic gain-of-function in absence seizures
    Crunelli, Vincenzo
    Leresche, Nathalie
    Cope, David W.
    EPILEPSIA, 2010, 51 : 23 - 23